| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/21/1999 | WO1999002675A1 G-coupled receptor showing selective affinity for atp |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002667A1 Mutations in the myostation gene cause double-muscling in mammals |
| 01/21/1999 | WO1999002656A1 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/21/1999 | WO1999002655A1 Protein kinases and uses thereof |
| 01/21/1999 | WO1999002654A1 Isolation of bone and cartilage precursor cells |
| 01/21/1999 | WO1999002564A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | WO1999002563A1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/21/1999 | WO1999002562A1 Isolated dendritic cell membrane protein genes |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002556A1 Semaphorin receptors |
| 01/21/1999 | WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | WO1998046781A3 Novel transgene expression system for increased persistence |
| 01/21/1999 | WO1998046768A3 Phenolic acid esterase and use thereof |
| 01/21/1999 | WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2296759A1 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/21/1999 | CA2296434A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 01/21/1999 | CA2296071A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | CA2295914A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 01/21/1999 | CA2295908A1 New human growth regulator protein |
| 01/21/1999 | CA2295539A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2295474A1 123 human secreted proteins |
| 01/21/1999 | CA2295375A1 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | CA2295320A1 Coffee storage proteins |
| 01/21/1999 | CA2295218A1 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | CA2295202A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | CA2295149A1 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | CA2295086A1 Wa545 compositions |
| 01/21/1999 | CA2294752A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2290716A1 Fusion proteins comprising coiled-coil structures |
| 01/21/1999 | CA2265441A1 Protein kinases and uses thereof |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892055A2 GidB polypeptides from Staphylococcus aureus |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0892050A2 Human HFIZG53 |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0892047A2 Human and murine semaphorin L |
| 01/20/1999 | EP0892046A2 Melatonin-receptor expression cells and their uses |
| 01/20/1999 | EP0891550A1 A method of enriching rare cells |
| 01/20/1999 | EP0891549A2 Foetal cell analysis |
| 01/20/1999 | EP0891547A1 $i(IN VITRO) ASSAY FOR IDENTIFICATION OF CARCINOGENS |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891428A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/20/1999 | EP0891427A1 Expression of hgv antigens and their use |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891421A1 Bioactive material substrate for enhanced cellular attachment and function |
| 01/20/1999 | EP0891420A1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 01/20/1999 | EP0891419A1 Hematopoietic cell culture nutrient supplement |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891134A1 Use of arabinogalactan in cell cryopreservation media |
| 01/20/1999 | EP0445228B1 Immunotherapy involving cd28 stimulation |
| 01/20/1999 | EP0380646B1 Use of leukaemia inhibitory factor (lif) for the (in vitro) propagation of embryonic stem cells |
| 01/20/1999 | CN1205740A Diagnosis and treatment of Aur-1 and/or Aur-2 related disorders |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/20/1999 | CN1205737A Improved immortalized human skin cell lines and novel serum-free medium useful for prodn. thereof |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/19/1999 | US5861543 Dna and amino acid sequences encoding a protein; plant cells such as corn transformed by the dna to be resistant to lepidopteran insects |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861490 Cd8 suppressor molecule, fractionation of media and identification of fractions |
| 01/19/1999 | US5861488 Gene therapy and gene expression of antisickling globulin proteins |
| 01/19/1999 | US5861487 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
| 01/19/1999 | US5861484 Treatment of psoriasis, rheumatoid arthritis, hemangiomas, angiofibromas, diabetic retinopathy, neovascular glaucoma,and other vegf-induced pathological angiogenesis and vascular permeability conditions, such as tumor vascularization |
| 01/19/1999 | US5861315 Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861313 Method of isolating bile duct progenitor cells |
| 01/19/1999 | US5861312 Recognition component; hybridization; dna expression vectors; genetic engineering |
| 01/19/1999 | US5861311 Preserved, non-infectious control cells prepared by the modulation or modification of normal leukocytes |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861308 Isolated nucleic acids associated with T cell activation and uses thereof |
| 01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
| 01/19/1999 | US5861306 Multi-well bone culture device for use in assessment of bone cell activity |
| 01/19/1999 | US5861299 Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals |
| 01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 01/19/1999 | US5861259 Immunoassays for human cyclin E |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861158 Improving a transplantation of hematopoietic cells from a donor to a recipient |
| 01/19/1999 | US5861155 Humanized antibodies and uses thereof |
| 01/19/1999 | US5861153 Skin equivalent comprising langerhans' cells |
| 01/19/1999 | CA2105382C Recombinant hybrid porin epitopes |
| 01/19/1999 | CA2004632C Expression induction method |
| 01/19/1999 | CA1340324C Plants with modified stamen cells |
| 01/19/1999 | CA1340323C Rna catalyst for cleaving specific rna sequences |
| 01/18/1999 | CA2237143A1 Novel rata |
| 01/18/1999 | CA2237050A1 Histidine kinase |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |